8 completed, 1 not yet recruiting, 1 terminated. 5 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Not yet recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Obsessive Behavior: new trials by email Literature Review of Obsessive Behavior trials Research Report on Obsessive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digital OC Training in Children and Adolescents Digital behavioral training - Obsessive Compulsive Behavior | Not applicable | Not yet recruiting | Aarhus University Hospital | 20 | 2027-01-01 | 2026-10-08 |
| Obsessions and Suicidality in Youth With Bipolar 1 Disorder Psychometric assessment - Obsessions, Suicide | Completed | Cairo University | 80 | 2022-02-01 | 2023-05-26 | |
| Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts Emotion Regulation Therapy - Attention Regulation (AR-ERT), Supportive Psychotherapy (SPT) - Obsessive-Compulsive Disorder, Generalized Anxiety Disorder | Not applicable | Completed | Massachusetts General Hospital | 65 | 2021-04-30 | 2026-03-10 |
| Targeting Taboo Thoughts In Obsessive-Compulsive Disorder Online cognitive therapy (I-CT) - Obsessive-Compulsive Disorder | Not applicable | Completed | Karolinska Institutet | 19 | 2020-03-26 | 2021-08-17 |
| The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts" Cognitive Control Tasks and Script Driven Imagery - Obsessive-Compulsive Disorder, Generalized Anxiety Disorder | Not applicable | Completed | Massachusetts General Hospital | 75 | 2018-05-18 | 2020-03-18 |
| Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy AFQ056, Placebo - Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses | Phase 2 | Terminated | Novartis Pharmaceuticals | 50 | 2013-11-01 | 2017-01-02 |
| "Association Splitting" in Obsessive-Compulsive Disorder (OCD) "association splitting", cognitive remediation - Obsessive-Compulsive Disorder | Not applicable | Completed | Universitätsklinikum Hamburg-Eppendorf | 156 | 2009-03-01 | 2015-03-25 |
| Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) Duloxetine - Obsessive Compulsive Disorder | Phase 4 | Completed | Massachusetts General Hospital | 20 | 2005-12-01 | 2019-03-19 |
| Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder Topiramate - Obsessive-Compulsive Disorder | Phase 3 | Completed | University of Florida | 96 | 2003-01-01 | 2011-10-05 |
| Genetics of Obsessive-Compulsive Disorder Obsessive Compulsive Disorder | Completed | National Institute of Mental Health (NIMH) | 1067 | 1996-08-22 | 2017-10-06 |
Obsessive-Compulsive Disorder (9) · Compulsive Behavior (5) · Depressive Disorder, Major (2) · Generalized Anxiety Disorder (2) · Rumination Syndrome (2) · Bipolar Disorder (1) · Mental Disorders (1) · Suicide (1) · Tourette Syndrome (1) · Trichotillomania (1)
Behavior (10) · Behavioral Symptoms (10) · Anxiety Disorders (9) · Mental Disorders (8) · Impulsive Behavior (5) · Mood Disorders (3) · Depressive Disorder (2) · Digestive System Diseases (2) · Feeding and Eating Disorders (2) · Gastrointestinal Diseases (2) · Basal Ganglia Diseases (1) · Bipolar and Related Disorders (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Cognitive Remediation (1) · Duloxetine Hydrochloride (1) · Topiramate (1) · mavoglurant (1)
Massachusetts General Hospital (3) · Aarhus University Hospital (1) · Cairo University (1) · Karolinska Institutet (1) · National Institute of Mental Health (NIMH) (1) · Novartis Pharmaceuticals (1) · University of Florida (1) · Universitätsklinikum Hamburg-Eppendorf (1)
United States (6) · Germany (2) · Bulgaria (1) · Czechia (1) · Egypt (1) · Sweden (1) · Switzerland (1)
Ryan J Jacoby, Ph.D. (2) · Darin D Dougherty, MD (1) · Erik Andersson, PhD (1) · Francis J McMahon, M.D. (1) · Herbert E Ward, MD (1) · Lena Jelinek, PhD (1) · Steffen Moritz, PhD (1)
PMID 24929782, PMID 25637377, PMID 28044255, PMID 39626971
K23MH120351 (1)